MAPT and amyotrophic lateral sclerosis: For instance, elevated levels of total tau (t-tau) and the lowered ratio of phosphorylated tau (p-tau)/t-tau in cerebrospinal fluid (CSF) have emerged as potential diagnostic biomarkers for ALS [41].